EHC: Encompass Health Inc. EV/EBITDA Multiple
Demand for inpatient rehabilitation is rising due to the aging US population, which is increasing center occupancy rates for Encompass Health (EHC). This EV/EBITDA chart illustrates current valuation trends, where the value 11.35 characterizes this level. The expansion of the hospital network and a shortage of beds are stimulating growth, while centralized pharmaceutical procurement minimizes logistical risks, supporting high business profitability.
EHC (encompasshealth.com): analytical breakdowns and indicator data
- stock price and consensus target price:
- market capitalization information:
- issuer book value statistics:
- debt and liquidity data:
Debt to Equity Encompass Health|EHC - Long-Term Liabilities to Capital|Short-Term Debt to Equity Encompass Health Corporation|EHC - Company Total Debt|Debt to Book Capitalization Ratio Encompass|EHC - Long-Term Liabilities|Company Short-Term Debts Encompass Health|Quick Liquidity encompasshealth.com
- business earnings and investment ratios data:
EHC - Net Financial Result|Expected Profit Encompass Health|EHC - Business Payback Period|Projected Price to Earnings Encompass Health|EHC - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Encompass|EHC - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Encompass Health|EHC - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth encompasshealth.com|EHC - Earnings growth in current year|Net earnings per share growth forecast for next year Encompass Health
Analysis of all company metrics:EHC (Encompass Health Inc.)
This metric combines market capitalization and net debt, comparing them against operating profit before taxes, depreciation, and amortization. The metric determines the real value of the business, identifying risks of a disconnect between borrowing growth and earnings. For Encompass Health, which is expanding capacity with low R&D expenditures, the 11.35 value reflects the efficiency of capital expenditures. The EV/EBITDA ratio dynamics, accounting for the capital structure, confirm the sustainability of the development model.
Direct competitors
HCA Healthcare - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio THC (Tenet Health)|Fresenius Medical Care - EV/EBITDA Multiple|Company Value to EBITDA solventum.com|uhsinc.com (UHS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation DVA|RDNT (RadNet Corp) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Option Care Corp (OPCH)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surgery Partners, Inc. (SGRY)|PINC - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization National Vision EYE|PGNY - Enterprise Value to EBITDA Ratio|ARDT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio SEM|ASTH: EV/EBITDA Multiple|Pediatrix Medical Group (MD) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization US Physical Therapy|Pennant Group (PNTG) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Organogenesis Inc. (ORGO)|Total Company Value to Operating Income Before Depreciation Ratio Nutex Health Hospitals|Auna SA - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation SBC|Evolus - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation CYH (CHS)|SKIN: EV/EBITDA Multiple|Company Value to EBITDA MediWound (MDWD)|BTMD (biote Corp.) - EV/EBITDA Multiple|EV/EBITDA Multiple thejoint.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization DocGo (DCGO)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization PIII (p3hp.org)|Gain Therapeutics, Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio EUDA (euda.com)|Basel Medical Group Limited - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation CLGN (CollPlant Biotechnologies)|CUPR: EV/EBITDA Multiple|Company Value to EBITDA Concord Medical Services Holdings (CCM)|AMS (American Shared Hospital Services, Inc.) - EV/EBITDA Multiple|MRM: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ALBT|Enterprise Value to EBITDA Ratio dih.com DHAI|Carmell Therapeutics - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio NIVF (NewGenIvf Group)|ATIP - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation CMAX (CareMax, Inc)|KDLY: EV/EBITDA Multiple|Company Value to EBITDA modivcare.com (MODV)|NVOS (Novo Integrated Sciences, Inc.) - EV/EBITDA Multiple|EV/EBITDA Multiple SunLink Health Systems, Inc|Enterprise Value to EBITDA Ratio BACK (IMAC Regeneration Centers)
